Detalhe da pesquisa
1.
Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.
Mol Med
; 30(1): 13, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243170
2.
Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study.
Int Immunopharmacol
; 127: 111413, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118318
3.
PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial.
Med
; 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795703
4.
Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer.
Gastroenterol Rep (Oxf)
; 11: goad014, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056281
5.
Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma.
J Cancer
; 14(16): 2998-3008, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37859817
6.
Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy.
Acta Pharm Sin B
; 13(8): 3382-3399, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655321
7.
Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity.
Cell Res
; 32(12): 1086-1104, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280710
8.
RAB31 marks and controls an ESCRT-independent exosome pathway.
Cell Res
; 31(2): 157-177, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958903
9.
CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma.
Theranostics
; 7(14): 3478-3488, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28912889
10.
RMI2 plays crucial roles in growth and metastasis of lung cancer.
Signal Transduct Target Ther
; 5(1): 188, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883952